Foghorn Therapeutics

$11.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.28 (-2.38%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell FHTX and other stocks, options, and ETFs commission-free!

About FHTX

Foghorn Therapeutics Inc. Common Stock, also called Foghorn Therapeutics, is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology.

CEO
Adrian Gottschalk
Employees
95
Headquarters
Cambridge, Massachusetts
Founded
2015
Market Cap
438.85M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
50.06K
High Today
$12.05
Low Today
$11.20
Open Price
$11.89
Volume
50.38K
52 Week High
$28.27
52 Week Low
$11.20

FHTX Earnings

-$3.12
-$1.24
$0.65
$2.53
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, After Hours

You May Also Like

PSCC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure